A Study of Atezolizumab in Combination With Bevacizumab in Untreated Locally Advanced or Metastatic Clear Cell or Non-Clear Cell Renal Cell Carcinoma
Clinical trial NCT03693573 · WITHDRAWN
Trial details
- NCT number
- NCT03693573
- Sponsor
- Hoffmann-La Roche
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-11
- Primary completion
- 2021-08-14
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.